<DOC>
	<DOCNO>NCT01713309</DOCNO>
	<brief_summary>This study plasma HBP -levels previously publish trial G-CSF critically ill patient ( Pettila et al . Critical Care Medicine 2000 ) . The original study prospective , randomised , double-blind , placebo-controlled trial filgrastim patient acute respiratory failure require intubation . In substudy , investigator evaluate effect filgrastim HBP -concentrations critically ill patient .</brief_summary>
	<brief_title>Heparin Binding Protein Patients With Acute Respiratory Failure Treated With GCSF ( Filgrastim )</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Antimicrobial Cationic Peptides</mesh_term>
	<criteria>Criteria original study . For substudy , patient include . Age &gt; 18 year Admitted ICU longer 12 hr study entry Intubated ventilation insufficiency longer 48 hr study entry Clinically expect stay ICU &gt; 48 hr Informed consent Pregnant nursing Total leukocyte count &gt; 50,000/mm3 Administration filgrastim , sargramostim , biological response modifier within 7 day study entry Known hypersensitivity allergic reaction Escherichia coliderived product Participation another drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Filgrastim</keyword>
	<keyword>G-CSF</keyword>
	<keyword>Heparin-binding protein</keyword>
	<keyword>critically ill</keyword>
	<keyword>acute respiratory failure</keyword>
</DOC>